Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1997;96:396-399

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mach, F.
Right arrow Articles by Libby, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mach, F.
Right arrow Articles by Libby, P.
Right arrowPubmed/NCBI databases
*Substance via MeSH

(Circulation. 1997;96:396-399.)
© 1997 American Heart Association, Inc.


Articles

Activation of Monocyte/Macrophage Functions Related to Acute Atheroma Complication by Ligation of CD40

Induction of Collagenase, Stromelysin, and Tissue Factor

François Mach, MD; Uwe Schönbeck, PhD; Jean-Yves Bonnefoy, PhD; Jordan S. Pober, MD, PhD; ; Peter Libby, MD

From the Vascular Medicine and Atherosclerosis Unit (F.M., U.S., P.L.), Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass; the Geneva Biomedical Research Institute (J.-Y.B.), Geneva, Switzerland; and the Molecular Cardiobiology Program, Boyer Center for Molecular Medicine (J.S.P), Yale University School of Medicine, New Haven, Conn.

Correspondence to Peter Libby, MD, Vascular Medicine and Atherosclerosis Unit, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 221 Longwood Ave, LMRC 307, Boston, MA 02115. E-mail plibby{at}bustoff.bwh.harvard.edu

Background Plaque disruption with thrombosis commonly causes the acute coronary syndromes. Macrophages, abundant at sites of plaque rupture, release proteinases that weaken plaques and express tissue factor (TF), which initiates thrombosis. The signals that induce expression of these macrophage functions, particularly TF, remain obscure. Recent studies have localized the receptor CD40 and its ligand in human atheroma. This study tested the hypothesis that ligation of CD40 can activate key mononuclear phagocyte functions related to clinical manifestations of atheroma.

Methods and Results Stimulation of human monocytes/macrophages through CD40 by either membranes from activated T cells or recombinant CD40L (rCD40L) induced expression of interstitial collagenase, stromelysin, and TF protein and activity. In contrast, the soluble cytokines interleukin-1 or tumor necrosis factor-{alpha} did not induce or weakly induced TF expression. Neutralization with anti-CD40L antibody markedly inhibited these actions of both T-cell membranes and rCD40L.

Conclusions By inducing the expression of matrix-degrading proteinases and of TF procoagulant, CD40 signaling may contribute to the triggering of acute coronary events.


Key Words: CD40 ligands • atheroma • thrombosis • plaque • macrophages




This article has been cited by other articles:


Home page
J. Lipid Res.Home page
P. Libby
Molecular and cellular mechanisms of the thrombotic complications of atherosclerosis
J. Lipid Res., April 1, 2009; 50(Supplement): S352 - S357.
[Abstract] [Full Text] [PDF]


Home page
PhysiologyHome page
L. Burnier, P. Fontana, A. Angelillo-Scherrer, and B. R. Kwak
Intercellular Communication in Atherosclerosis
Physiology, February 1, 2009; 24(1): 36 - 44.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. C. Newby
Metalloproteinase Expression in Monocytes and Macrophages and its Relationship to Atherosclerotic Plaque Instability
Arterioscler Thromb Vasc Biol, December 1, 2008; 28(12): 2108 - 2114.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
R. R.S. Packard, E. Maganto-Garcia, I. Gotsman, I. Tabas, P. Libby, and A. H. Lichtman
CD11c+ Dendritic Cells Maintain Antigen Processing, Presentation Capabilities, and CD4+ T-Cell Priming Efficacy Under Hypercholesterolemic Conditions Associated With Atherosclerosis
Circ. Res., October 24, 2008; 103(9): 965 - 973.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. Libby, M. Nahrendorf, M. J. Pittet, and F. K. Swirski
Diversity of Denizens of the Atherosclerotic Plaque: Not All Monocytes Are Created Equal
Circulation, June 24, 2008; 117(25): 3168 - 3170.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
Z. Touat, L. Lepage, V. Ollivier, P. Nataf, U. Hvass, J. Labreuche, M. Jandrot-Perrus, J.-B. Michel, and G. Jondeau
Dilation-Dependent Activation of Platelets and Prothrombin in Human Thoracic Ascending Aortic Aneurysm
Arterioscler Thromb Vasc Biol, May 1, 2008; 28(5): 940 - 946.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
R. R. S. Packard and P. Libby
Inflammation in Atherosclerosis: From Vascular Biology to Biomarker Discovery and Risk Prediction
Clin. Chem., January 1, 2008; 54(1): 24 - 38.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. Ferro, L. Loffredo, L. Polimeni, F. Fimognari, P. Villari, P. Pignatelli, V. Fuster, and F. Violi
Soluble CD40 Ligand Predicts Ischemic Stroke and Myocardial Infarction in Patients With Nonvalvular Atrial Fibrillation
Arterioscler Thromb Vasc Biol, December 1, 2007; 27(12): 2763 - 2768.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. Korff, K. Aufgebauer, and M. Hecker
Cyclic Stretch Controls the Expression of CD40 in Endothelial Cells by Changing Their Transforming Growth Factor-{beta}1 Response
Circulation, November 13, 2007; 116(20): 2288 - 2297.
[Abstract] [Full Text] [PDF]


Home page
CLIN APPL THROMB HEMOSTHome page
I. Alacacioglu, M. A. Ozcan, O. Piskin, F. Yuksel, A. Alacacioglu, F. Demirkan, H. G. Ozsan, M. Polat, Y. Ozgenc, and B. Undar
Increased Concentration of Soluble CD40 Ligand in Preeclampsia
Clinical and Applied Thrombosis/Hemostasis, April 1, 2007; 13(2): 201 - 205.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
P. Libby and P. M. Ridker
Inflammation and Atherothrombosis: From Population Biology and Bench Research to Clinical Practice
J. Am. Coll. Cardiol., October 27, 2006; 48(9_Suppl_A): A33 - A46.
[Abstract] [Full Text] [PDF]


Home page
PERSPECT VASC SURG ENDOVASC THERHome page
G. Aidinian, J. M. Weiswasser, S. Arora, C. J. Abularrage, N. Singh, and A. N. Sidawy
Carotid Plaque Morphologic Characteristics
Perspectives in Vascular Surgery and Endovascular Therapy, March 1, 2006; 18(1): 63 - 70.
[Abstract] [PDF]


Home page
CirculationHome page
J. Steffel, T. F. Luscher, and F. C. Tanner
Tissue Factor in Cardiovascular Diseases: Molecular Mechanisms and Clinical Implications
Circulation, February 7, 2006; 113(5): 722 - 731.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
P. Libby
Inflammation and cardiovascular disease mechanisms
Am. J. Clinical Nutrition, February 1, 2006; 83(2): 456S - 460S.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. A. de Lemos, A. Zirlik, U. Schonbeck, N. Varo, S. A. Murphy, A. Khera, D. K. McGuire, G. Stanek, H. S. Lo, R. Nuzzo, et al.
Associations Between Soluble CD40 Ligand, Atherosclerosis Risk Factors, and Subclinical Atherosclerosis: Results from the Dallas Heart Study
Arterioscler Thromb Vasc Biol, October 1, 2005; 25(10): 2192 - 2196.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
G. K. Hansson
Inflammation, Atherosclerosis, and Coronary Artery Disease
N. Engl. J. Med., April 21, 2005; 352(16): 1685 - 1695.
[Full Text] [PDF]


Home page
Physiol. Rev.Home page
A. C. Newby
Dual Role of Matrix Metalloproteinases (Matrixins) in Intimal Thickening and Atherosclerotic Plaque Rupture
Physiol Rev, January 1, 2005; 85(1): 1 - 31.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Fleiner, M. Kummer, M. Mirlacher, G. Sauter, G. Cathomas, R. Krapf, and B. C. Biedermann
Arterial Neovascularization and Inflammation in Vulnerable Patients: Early and Late Signs of Symptomatic Atherosclerosis
Circulation, November 2, 2004; 110(18): 2843 - 2850.
[Abstract] [Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
D. Vishnevetsky, V. A Kiyanista, and P. J Gandhi
CD40 Ligand: A Novel Target in the Fight Against Cardiovascular Disease
Ann. Pharmacother., September 1, 2004; 38(9): 1500 - 1508.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Walter-Yohrling, X. Cao, M. Callahan, W. Weber, S. Morgenbesser, S. L. Madden, C. Wang, and B. A. Teicher
Identification of Genes Expressed in Malignant Cells That Promote Invasion
Cancer Res., December 15, 2003; 63(24): 8939 - 8947.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
A. Lafont
Basic aspects of plaque vulnerability
Heart, October 1, 2003; 89(10): 1262 - 1267.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
C. B Jones, D. C Sane, and D. M Herrington
Matrix metalloproteinases: A review of their structure and role in acute coronary syndrome
Cardiovasc Res, October 1, 2003; 59(4): 812 - 823.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
D Tousoulis, G Davies, C Stefanadis, P Toutouzas, and J A Ambrose
Inflammatory and thrombotic mechanisms in coronary atherosclerosis
Heart, September 1, 2003; 89(9): 993 - 997.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
Z. Li, L. Sun, H. Zhang, Y. Liao, D. Wang, B. Zhao, Z. Zhu, J. Zhao, A. Ma, Y. Han, et al.
Elevated Plasma Homocysteine Was Associated With Hemorrhagic and Ischemic Stroke, but Methylenetetrahydrofolate Reductase Gene C677T Polymorphism Was a Risk Factor for Thrombotic Stroke: A Multicenter Case-Control Study in China
Stroke, September 1, 2003; 34(9): 2085 - 2090.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Contin, V. Pitard, T. Itai, S. Nagata, J.-F. Moreau, and J. Dechanet-Merville
Membrane-anchored CD40 Is Processed by the Tumor Necrosis Factor-{alpha}-converting Enzyme: IMPLICATIONS FOR CD40 SIGNALING
J. Biol. Chem., August 29, 2003; 278(35): 32801 - 32809.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. E. J. Reinders, M. Sho, S. W. Robertson, C. S. Geehan, and D. M. Briscoe
Proangiogenic Function of CD40 Ligand-CD40 Interactions
J. Immunol., August 1, 2003; 171(3): 1534 - 1541.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
C.D. Garlichs, S. Kozina, S. Fateh-Moghadam, B. Tomandl, C. Stumpf, S. Eskafi, D. Raaz, A. Schmeisser, A. Yilmaz, J. Ludwig, et al.
Upregulation of CD40-CD40 Ligand (CD154) in Patients With Acute Cerebral Ischemia
Stroke, June 1, 2003; 34(6): 1412 - 1418.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
D. P. Inwald, A. McDowall, M. J. Peters, R. E. Callard, and N. J. Klein
CD40 Is Constitutively Expressed on Platelets and Provides a Novel Mechanism for Platelet Activation
Circ. Res., May 16, 2003; 92(9): 1041 - 1048.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. Li, L. Liu, H. Chen, T. Sawamura, and J. L. Mehta
LOX-1, an Oxidized LDL Endothelial Receptor, Induces CD40/CD40L Signaling in Human Coronary Artery Endothelial Cells
Arterioscler Thromb Vasc Biol, May 1, 2003; 23(5): 816 - 821.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
C. Heeschen, S. Dimmeler, C. W. Hamm, M. J. van den Brand, E. Boersma, A. M. Zeiher, M. L. Simoons, and the CAPTURE Study Investigators
Soluble CD40 Ligand in Acute Coronary Syndromes
N. Engl. J. Med., March 20, 2003; 348(12): 1104 - 1111.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
G. J. Blake, R. J. Ostfeld, E. K. Yucel, N. Varo, U. Schonbeck, M. A. Blake, M. Gerhard, P. M. Ridker, P. Libby, and R. T. Lee
Soluble CD40 Ligand Levels Indicate Lipid Accumulation in Carotid Atheroma: An In Vivo Study With High-Resolution MRI
Arterioscler Thromb Vasc Biol, January 1, 2003; 23(1): e11 - 14.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
Y. Gidron, H. Gilutz, R. Berger, and M. Huleihel
Molecular and cellular interface between behavior and acute coronary syndromes
Cardiovasc Res, October 1, 2002; 56(1): 15 - 21.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
G. K. Hansson, P. Libby, U. Schonbeck, and Z.-Q. Yan
Innate and Adaptive Immunity in the Pathogenesis of Atherosclerosis
Circ. Res., August 23, 2002; 91(4): 281 - 291.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
U. Bavendiek, P. Libby, M. Kilbride, R. Reynolds, N. Mackman, and U. Schonbeck
Induction of Tissue Factor Expression in Human Endothelial Cells by CD40 Ligand Is Mediated via Activator Protein 1, Nuclear Factor kappa B, and Egr-1
J. Biol. Chem., July 5, 2002; 277(28): 25032 - 25039.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
J. B. Sakash, G. I. Byrne, A. Lichtman, and P. Libby
Cytokines Induce Indoleamine 2,3-Dioxygenase Expression in Human Atheroma-Associated Cells: Implications for Persistent Chlamydophila pneumoniae Infection
Infect. Immun., July 1, 2002; 70(7): 3959 - 3961.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
T. C. Major, L. Liang, X. Lu, W. Rosebury, and T. M.A. Bocan
Extracellular Matrix Metalloproteinase Inducer (EMMPRIN) Is Induced Upon Monocyte Differentiation and Is Expressed in Human Atheroma
Arterioscler Thromb Vasc Biol, July 1, 2002; 22(7): 1200 - 1207.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
L. J. Pinderski, M. P. Fischbein, G. Subbanagounder, M. C. Fishbein, N. Kubo, H. Cheroutre, L. K. Curtiss, J. A. Berliner, and W. A. Boisvert
Overexpression of Interleukin-10 by Activated T Lymphocytes Inhibits Atherosclerosis in LDL Receptor-Deficient Mice by Altering Lymphocyte and Macrophage Phenotypes
Circ. Res., May 31, 2002; 90(10): 1064 - 1071.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
C. Monaco, E. Andreakos, S. Young, M. Feldmann, and E. Paleolog
T cell-mediated signaling to vascular endothelium: induction of cytokines, chemokines, and tissue factor
J. Leukoc. Biol., April 1, 2002; 71(4): 659 - 668.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
J. Kim and R. A. Feldman
Activated Fes Protein Tyrosine Kinase Induces Terminal Macrophage Differentiation of Myeloid Progenitors (U937 Cells) and Activation of the Transcription Factor PU.1
Mol. Cell. Biol., March 15, 2002; 22(6): 1903 - 1918.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
Z. S. Galis and J. J. Khatri
Matrix Metalloproteinases in Vascular Remodeling and Atherogenesis: The Good, the Bad, and the Ugly
Circ. Res., February 22, 2002; 90(3): 251 - 262.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. Nakajima, S. Schulte, K. J. Warrington, S. L. Kopecky, R. L. Frye, J. J. Goronzy, and C. M. Weyand
T-Cell-Mediated Lysis of Endothelial Cells in Acute Coronary Syndromes
Circulation, February 5, 2002; 105(5): 570 - 575.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. H.M Moons, M. Levi, and R. J.G Peters
Tissue factor and coronary artery disease
Cardiovasc Res, February 1, 2002; 53(2): 313 - 325.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
U. Schonbeck and P. Libby
CD40 Signaling and Plaque Instability
Circ. Res., December 7, 2001; 89(12): 1092 - 1103.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
C D Garlichs, S Eskafi, D Raaz, A Schmidt, J Ludwig, M Herrmann, L Klinghammer, W G Daniel, and A Schmeisser
Patients with acute coronary syndromes express enhanced CD40 ligand/CD154 on platelets
Heart, December 1, 2001; 86(6): 649 - 655.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Bobik and N. Kalinina
Tumor Necrosis Factor Receptor and Ligand Superfamily Family Members TNFRSF14 and LIGHT: New Players in Human Atherogenesis
Arterioscler Thromb Vasc Biol, December 1, 2001; 21(12): 1873 - 1875.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
G. K. Hansson
Immune Mechanisms in Atherosclerosis
Arterioscler Thromb Vasc Biol, December 1, 2001; 21(12): 1876 - 1890.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
G. J. Blake and P. M. Ridker
Novel Clinical Markers of Vascular Wall Inflammation
Circ. Res., October 26, 2001; 89(9): 763 - 771.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. K. Shah and Z. S. Galis
Matrix Metalloproteinase Hypothesis of Plaque Rupture: Players Keep Piling Up But Questions Remain
Circulation, October 16, 2001; 104(16): 1878 - 1880.
[Full Text] [PDF]


Home page
Circ. Res.Home page
P. Libby and U. Schonbeck
Drilling for Oxygen: Angiogenesis Involves Proteolysis of the Extracellular Matrix
Circ. Res., August 3, 2001; 89(3): 195 - 197.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. A. Houtkamp, A. C. van der Wal, O. J. de Boer, C. M. van der Loos, P. A. J. de Boer, A. F. M. Moorman, and A. E. Becker
Interleukin-15 Expression in Atherosclerotic Plaques : An Alternative Pathway for T-Cell Activation in Atherosclerosis?
Arterioscler Thromb Vasc Biol, July 1, 2001; 21(7): 1208 - 1213.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
T. Kislinger, N. Tanji, T. Wendt, W. Qu, Y. Lu, L. J. Ferran Jr, A. Taguchi, K. Olson, L. Bucciarelli, M. Goova, et al.
Receptor for Advanced Glycation End Products Mediates Inflammation and Enhanced Expression of Tissue Factor in Vasculature of Diabetic Apolipoprotein E-Null Mice
Arterioscler Thromb Vasc Biol, June 1, 2001; 21(6): 905 - 910.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
M. Aikawa and P. Libby
Vascular inflammation and activation: new targets for lipid lowering
Eur. Heart J. Suppl., May 1, 2001; 3(suppl_B): B3 - B11.
[Abstract] [PDF]


Home page
CirculationHome page
P. Libby and D. I. Simon
Inflammation and Thrombosis : The Clot Thickens
Circulation, April 3, 2001; 103(13): 1718 - 1720.
[Full Text] [PDF]


Home page
StrokeHome page
S. Jander, M. Sitzer, A. Wendt, M. Schroeter, M. Buchkremer, M. Siebler, W. Muller, W. Sandmann, and G. Stoll
Expression of Tissue Factor in High-Grade Carotid Artery Stenosis : Association With Plaque Destabilization
Stroke, April 1, 2001; 32(4): 850 - 854.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
G. Liuzzo, A. N. Vallejo, S. L. Kopecky, R. L. Frye, D. R. Holmes, J. J. Goronzy, and C. M. Weyand
Molecular Fingerprint of Interferon-{{gamma}} Signaling in Unstable Angina
Circulation, March 20, 2001; 103(11): 1509 - 1514.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. Remskar, H. Li, K.-Y. Chyu, P. K. Shah, and B. Cercek
Absence of CD40 Signaling Is Associated With an Increase in Intimal Thickening After Arterial Injury
Circ. Res., March 2, 2001; 88(4): 390 - 394.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
D M Braganza and M R Bennett
New insights into atherosclerotic plaque rupture
Postgrad. Med. J., February 1, 2001; 77(904): 94 - 98.
[Full Text]


Home page
CirculationHome page
N. Marx, N. Mackman, U. Schonbeck, N. Yilmaz, V. Hombach, P. Libby, and J. Plutzky
PPAR{{alpha}} Activators Inhibit Tissue Factor Expression and Activity in Human Monocytes
Circulation, January 16, 2001; 103(2): 213 - 219.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Aikawa, E. Rabkin, S. Sugiyama, S. J. Voglic, Y. Fukumoto, Y. Furukawa, M. Shiomi, F. J. Schoen, and P. Libby
An HMG-CoA Reductase Inhibitor, Cerivastatin, Suppresses Growth of Macrophages Expressing Matrix Metalloproteinases and Tissue Factor In Vivo and In Vitro
Circulation, January 16, 2001; 103(2): 276 - 283.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
R. Rauramaa, S. B. Vaisanen, L.-A. Luong, A. Schmidt-Trucksass, I. M. Penttila, C. Bouchard, J. Toyry, and S. E. Humphries
Stromelysin-1 and Interleukin-6 Gene Promoter Polymorphisms Are Determinants of Asymptomatic Carotid Artery Atherosclerosis
Arterioscler Thromb Vasc Biol, December 1, 2000; 20(12): 2657 - 2662.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. M. Waugh, J. Li-Hawkins, E. Yuksel, M. D. Kuo, P. N. Cifra, P. R. Hilfiker, R. Geske, M. Chawla, J. Thomas, S. M. Shenaq, et al.
Thrombomodulin Overexpression to Limit Neointima Formation
Circulation, July 18, 2000; 102(3): 332 - 337.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
U. Schonbeck, G. K. Sukhova, K. Shimizu, F. Mach, and P. Libby
Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice
PNAS, June 20, 2000; 97(13): 7458 - 7463.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
E. Lutgens, K. B. J. M. Cleutjens, S. Heeneman, V. E. Koteliansky, L. C. Burkly, and M. J. A. P. Daemen
Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype
PNAS, June 20, 2000; 97(13): 7464 - 7469.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Chizzolini, R. Rezzonico, C. De Luca, D. Burger, and J.-M. Dayer
Th2 Cell Membrane Factors in Association with IL-4 Enhance Matrix Metalloproteinase-1 (MMP-1) While Decreasing MMP-9 Production by Granulocyte-Macrophage Colony-Stimulating Factor-Differentiated Human Monocytes
J. Immunol., June 1, 2000; 164(11): 5952 - 5960.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
J. Golledge, R. M. Greenhalgh, and A. H. Davies
The Symptomatic Carotid Plaque
Stroke, March 1, 2000; 31(3): 774 - 781.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
U. Schonbeck, F. Mach, G. K. Sukhova, M. Herman, P. Graber, M. R. Kehry, and P. Libby
CD40 Ligation Induces Tissue Factor Expression in Human Vascular Smooth Muscle Cells
Am. J. Pathol., January 1, 2000; 156(1): 7 - 14.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. J. Pinderski Oslund, C. C. Hedrick, T. Olvera, A. Hagenbaugh, M. Territo, J. A. Berliner, and A. I. Fyfe
Interleukin-10 Blocks Atherosclerotic Events In Vitro and In Vivo
Arterioscler Thromb Vasc Biol, December 1, 1999; 19(12): 2847 - 2853.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
U. Schonbeck, G. K. Sukhova, P. Graber, S. Coulter, and P. Libby
Augmented Expression of Cyclooxygenase-2 in Human Atherosclerotic Lesions
Am. J. Pathol., October 1, 1999; 155(4): 1281 - 1291.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Aikawa, S. J. Voglic, S. Sugiyama, E. Rabkin, M. B. Taubman, J. T. Fallon, and P. Libby
Dietary Lipid Lowering Reduces Tissue Factor Expression in Rabbit Atheroma
Circulation, September 14, 1999; 100(11): 1215 - 1222.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. Aukrust, F. Muller, T. Ueland, T. Berget, E. Aaser, A. Brunsvig, N. O. Solum, K. Forfang, S. S. Froland, and L. Gullestad
Enhanced Levels of Soluble and Membrane-Bound CD40 Ligand in Patients With Unstable Angina : Possible Reflection of T Lymphocyte and Platelet Involvement in the Pathogenesis of Acute Coronary Syndromes
Circulation, August 10, 1999; 100(6): 614 - 620.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. E. Epstein, Y. F. Zhou, and J. Zhu
Infection and Atherosclerosis : Emerging Mechanistic Paradigms
Circulation, July 27, 1999; 100 (4): e20 - e28.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. C. Biedermann and J. S. Pober
Human Vascular Endothelial Cells Favor Clonal Expansion of Unusual Alloreactive CTL
J. Immunol., June 15, 1999; 162(12): 7022 - 7030.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
G. K. Sukhova, U. Schonbeck, E. Rabkin, F. J. Schoen, A. R. Poole, R. C. Billinghurst, and P. Libby
Evidence for Increased Collagenolysis by Interstitial Collagenases-1 and -3 in Vulnerable Human Atheromatous Plaques
Circulation, May 18, 1999; 99(19): 2503 - 2509.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
U. Schonbeck, F. Mach, G. K. Sukhova, E. Atkinson, E. Levesque, M. Herman, P. Graber, P. Basset, and P. Libby
Expression of Stromelysin-3 in Atherosclerotic Lesions: Regulation via CD40-CD40 Ligand Signaling In Vitro and In Vivo
J. Exp. Med., March 1, 1999; 189(5): 843 - 853.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. Rabbani and E. J. Topol
Strategies to achieve coronary arterial plaque stabilization
Cardiovasc Res, February 1, 1999; 41(2): 402 - 417.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
R. Ross
Atherosclerosis -- An Inflammatory Disease
N. Engl. J. Med., January 14, 1999; 340(2): 115 - 126.
[Full Text] [PDF]


Home page
Am. J. Pathol.Home page
F. Mach, U. Schonbeck, R. P. Fabunmi, C. Murphy, E. Atkinson, J.-Y. Bonnefoy, P. Graber, and P. Libby
T Lymphocytes Induce Endothelial Cell Matrix Metalloproteinase Expression by a CD40L-Dependent Mechanism : Implications for Tubule Formation
Am. J. Pathol., January 1, 1999; 154(1): 229 - 238.
[Abstract] [Full Text] [PDF]


Home page
Vasc MedHome page
P. Libby
The interface of atherosclerosis and thrombosis: basic mechanisms
Vascular Medicine, August 1, 1998; 3(3): 225 - 229.
[Abstract] [PDF]


Home page
CirculationHome page
M. Aikawa, E. Rabkin, Y. Okada, S. J. Voglic, S. K. Clinton, C. E. Brinckerhoff, G. K. Sukhova, and P. Libby
Lipid Lowering by Diet Reduces Matrix Metalloproteinase Activity and Increases Collagen Content of Rabbit Atheroma : A Potential Mechanism of Lesion Stabilization
Circulation, June 23, 1998; 97(24): 2433 - 2444.
[Abstract] [Full Text] [PDF]